Related Experiment Videos
[Microvessel count in normal cervical tissue and in cervical carcinomas]
1Department of Obstetric and Gynecology, Second Affiliated Hospital, WCUMS, Chengdu 610041.
Hua Xi Yi Ke Da Xue Xue Bao = Journal of West China University of Medical Sciences = Huaxi Yike Daxue Xuebao
|September 6, 2002
Summary
Microvessel count (MVC) is significantly higher in cervical carcinomas (CCs) than normal cervical tissue (NCT). Increased MVC correlates with advanced tumor stage and lymph node metastasis, suggesting its potential as an early diagnostic and prognostic marker for CCs.
Area of Science:
- Oncology
- Pathology
- Biomedical Engineering
Context:
- Cervical cancer (CC) is a significant global health concern.
- Accurate diagnostic and prognostic markers are crucial for effective CC management.
- Microvessel density is increasingly recognized as a factor in tumor progression.
Purpose:
- To investigate the microvessel count (MVC) in normal cervical tissue (NCT) and cervical carcinomas (CCs).
- To determine the correlation between MVC and clinicopathological features of CCs, including tumor stage, size, and lymph node status.
- To evaluate the potential of MVC as an early diagnostic and prognostic indicator for CCs.
Summary:
- Immunohistochemistry for Factor VIII related antigen (F8RA) was used to quantify MVC in 15 NCT and 80 CC cases.
- MVC was significantly elevated in CCs compared to NCT (P < 0.05).
- Higher MVC correlated with advanced clinical stage, larger tumor size, and positive lymph node status. Each 5-unit increase in MVC (at LM x 200) raised lymph node metastasis risk by 1.61 times. No correlation was found with tumor grade.
Impact:
- Microvessel count (MVC) may serve as a valuable early biomarker for cervical cancer (CC) diagnosis and prognosis.
- Findings contribute to understanding tumor angiogenesis in CC.
- This research supports the potential for MVC to guide clinical decision-making in CC treatment strategies.